Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): A multicentre, double-blind, randomised controlled trial

The Lancet Respiratory Medicine

Volumn 3, Issue 2, 2015, Pages 120-130

  Martineau, Adrian R ^a   James, Wai Yee ^a   Hooper, Richard L ^a   Barnes, Neil C ^a   Jolliffe, David A ^a   Greiller, Claire L ^a   Islam, Kamrul ^a   McLaughlin, David ^a   Bhowmik, Angshu ^b   Timms, Peter M ^b   Rajakulasingam, Raj K ^b   Rowe, Marion ^b   Venton, Timothy R ^b   Choudhury, Aklak B ^c   Simcock, David E ^d   Wilks, Mark ^d   Degun, Amarjeet ^d   Sadique, Zia ^e   Monteiro, William R ^f   Corrigan, Christopher J ^g   Hawrylowicz, Catherine M ^g   Griffiths, Christopher J ^a,g   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^c QUEEN S HOSPITAL   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f GLENFIELD HOSPITAL   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; COLECALCIFEROL; PLACEBO; 25-HYDROXYVITAMIN D; VITAMIN; VITAMIN D;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; COMPLICATION; DIET SUPPLEMENTATION; DIET THERAPY; MIDDLE AGED; MULTICENTER STUDY; RESPIRATORY TRACT INFECTIONS; VITAMIN D DEFICIENCY;

AGED; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84922021820     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70255-3     Document Type: Article

References (30)

1. Sapey E, Stockley RA COPD exacerbations. 2: Aetiology. Thorax 2006, 61:250-258.
2. Ginde AA, Mansbach JM, Camargo CA Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009, 169:384-390.
3. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009, 179:630-636.
4. Kunisaki KM, Niewoehner DE, Connett JE Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med 2012, 185:286-290.
5. Quint JK, Donaldson GC, Wassef N, Hurst JR, Thomas M, Wedzicha JA 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease. BMC Pulm Med 2012, 12:28.
6. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012, 156:105-114.
7. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1608-1613.
8. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31:416-469.
9. Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 169:1298-1303.
10. Payne L, Kuhlmann-Berenzon S, Ekdahl K, Giesecke J, Hogberg L, Penttinen P 'Did you have flu last week?' A telephone survey to estimate a point prevalence of influenza in the Swedish population. Euro Surveill 2005, 10:241-244.
11. Jackson GG, Dowling HF, Spiesman IG, Boand AV Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med 1958, 101:267-278.
12. Martineau AR, Hanifa Y, Hooper RL, et al. Increased risk of upper respiratory infection with addition of intermittent bolus-dose vitamin D supplementation to a daily low-dose regimen. Thorax 2013, 68(suppl 3):A64.
13. Maunsell Z, Wright DJ, Rainbow SJ Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005, 51:1683-1690.
14. Choudhury AB, Dawson CM, Kilvington HE, et al. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial. Respir Res 2007, 8:93.
15. Melchart D, Walther E, Linde K, Brandmaier R, Lersch C Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch Fam Med 1998, 7:541-545.
16. Schoenfeld DA, Richter JR Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982, 38:163-170.
17. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
18. Benjamini Y, Hochberg Y Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995, 57:289-300.
19. Janssens W, Decramer M, Mathieu C, Korf H Vitamin D and chronic obstructive pulmonary disease: hype or reality?. Lancet Respir Med 2013, 1:804-812.
20. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000, 55:114-120.
21. Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005, 25:640-646.
22. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012, 109:15449-15454.
23. Vieth R The pharmacology of vitamin D, including fortification strategies. Vitamin D 2005, Academic Press, London. F.H. Glorieux, J.W. Pike, D. Feldman (Eds.).
24. Ilahi M, Armas LA, Heaney RP Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008, 87:688-691.
25. McCambridge J, Witton J, Elbourne DR Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol 2014, 67:267-277.
26. Trivedi DP, Doll R, Khaw KT Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469.
27. Vieth R How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009, 29:3675-3684.
28. Martineau AR Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet 2012, 379:1373-1375.
29. Hollis BW, Wagner CL The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 2013, 98:4619-4628.
30. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007, 176:208-213.